vs
Side-by-side financial comparison of Information Services Group Inc. (III) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.
SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $61.2M, roughly 1.1× Information Services Group Inc.). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 4.3%, a 35.1% gap on every dollar of revenue. SOLENO THERAPEUTICS INC produced more free cash flow last quarter ($43.5M vs $4.3M).
EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
III vs SLNO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.2M | $66.0M |
| Net Profit | $2.6M | $26.0M |
| Gross Margin | 44.8% | 98.3% |
| Operating Margin | 8.4% | 33.5% |
| Net Margin | 4.3% | 39.4% |
| Revenue YoY | 5.9% | — |
| Net Profit YoY | -14.1% | 134.0% |
| EPS (diluted) | $0.06 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.2M | — | ||
| Q3 25 | $62.4M | $66.0M | ||
| Q2 25 | $61.6M | $32.7M | ||
| Q1 25 | $59.6M | — | ||
| Q4 24 | $57.8M | — | ||
| Q3 24 | $61.3M | — | ||
| Q2 24 | $64.3M | — | ||
| Q1 24 | $64.3M | — |
| Q4 25 | $2.6M | — | ||
| Q3 25 | $3.1M | $26.0M | ||
| Q2 25 | $2.2M | $-4.7M | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $-3.4M | — |
| Q4 25 | 44.8% | — | ||
| Q3 25 | 42.2% | 98.3% | ||
| Q2 25 | 42.2% | 97.9% | ||
| Q1 25 | 43.1% | — | ||
| Q4 24 | 41.5% | — | ||
| Q3 24 | 40.4% | — | ||
| Q2 24 | 39.5% | — | ||
| Q1 24 | 36.1% | — |
| Q4 25 | 8.4% | — | ||
| Q3 25 | 7.4% | 33.5% | ||
| Q2 25 | 7.6% | -20.0% | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 7.0% | — | ||
| Q2 24 | 5.7% | — | ||
| Q1 24 | -3.7% | — |
| Q4 25 | 4.3% | — | ||
| Q3 25 | 4.9% | 39.4% | ||
| Q2 25 | 3.5% | -14.4% | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | -5.3% | — |
| Q4 25 | $0.06 | — | ||
| Q3 25 | $0.06 | $0.47 | ||
| Q2 25 | $0.04 | $-0.09 | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $0.04 | — | ||
| Q1 24 | $-0.07 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.7M | $498.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $94.7M | $494.8M |
| Total Assets | $211.0M | $599.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.7M | — | ||
| Q3 25 | $28.7M | $498.9M | ||
| Q2 25 | $25.2M | $286.8M | ||
| Q1 25 | $20.1M | — | ||
| Q4 24 | $23.1M | — | ||
| Q3 24 | $9.7M | — | ||
| Q2 24 | $11.8M | — | ||
| Q1 24 | $14.0M | — |
| Q4 25 | $94.7M | — | ||
| Q3 25 | $94.7M | $494.8M | ||
| Q2 25 | $94.1M | $240.1M | ||
| Q1 25 | $95.0M | — | ||
| Q4 24 | $96.3M | — | ||
| Q3 24 | $96.6M | — | ||
| Q2 24 | $95.5M | — | ||
| Q1 24 | $95.6M | — |
| Q4 25 | $211.0M | — | ||
| Q3 25 | $213.3M | $599.9M | ||
| Q2 25 | $200.7M | $332.3M | ||
| Q1 25 | $202.4M | — | ||
| Q4 24 | $204.5M | — | ||
| Q3 24 | $227.1M | — | ||
| Q2 24 | $235.3M | — | ||
| Q1 24 | $234.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.1M | $43.5M |
| Free Cash FlowOCF − Capex | $4.3M | $43.5M |
| FCF MarginFCF / Revenue | 7.0% | 65.8% |
| Capex IntensityCapex / Revenue | 1.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.94× | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | $25.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | — | ||
| Q3 25 | $11.1M | $43.5M | ||
| Q2 25 | $11.9M | $-12.6M | ||
| Q1 25 | $978.0K | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $8.8M | — | ||
| Q2 24 | $2.2M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | $4.3M | — | ||
| Q3 25 | $9.5M | $43.5M | ||
| Q2 25 | $11.1M | $-12.6M | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $6.0M | — | ||
| Q3 24 | $8.4M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $1.3M | — |
| Q4 25 | 7.0% | — | ||
| Q3 25 | 15.2% | 65.8% | ||
| Q2 25 | 18.0% | -38.6% | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.5% | 0.0% | ||
| Q2 25 | 1.4% | 0.0% | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 1.94× | — | ||
| Q3 25 | 3.62× | 1.67× | ||
| Q2 25 | 5.46× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 2.15× | — | ||
| Q3 24 | 7.66× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
